InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Einhorn Andrew J., Chief Financial Officer. Insider active across 3 companies, notably Osmotica Pharmaceuticals plc. In total, 4 reports have been logged. The latest transaction was filed on 24 January 2022 — Retenue fiscale. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations4 total
€9,5729,607 shares@ €0.9963100.0% of flow
Ordinary Shares
SEC:0001104659-22-007844·
€9,5729,607 shares@ €0.996350.0% of flow
Ordinary Shares
SEC:0001104659-22-007844:0·
€16,5066,467 shares@ €2.5524100.0% of flow
Ordinary Shares
SEC:0001104659-21-069879·
€16,5066,467 shares@ €2.5524100.0% of flow
Ordinary Shares
SEC:0001104659-21-069879:0·
4 of 4 declarations
About Einhorn Andrew J.
Andrew J. Einhorn is the Chief Financial Officer at Osmotica Pharmaceuticals plc and RVL Pharmaceuticals plc. He oversees the financial management of the companies, ensuring compliance and efficiency in financial operations.
